Protein carbonyl groups as biomarkers of oxidative stress

Clinica Chimica Acta

Volumn 329, Issue 1-2, 2003, Pages 23-38

  Dalle Donne, Isabella ^a   Rossi, Ranieri ^b   Giustarini, Daniela ^b   Milzani, Aldo ^a   Colombo, Roberto ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b UNIVERSITY OF SIENA   (Italy)

Author keywords

2,4 Dinitrophenylhydrazine; Carbonyl assay; Human diseases; Oxyblot; Reactive oxygen species

Indexed keywords

2,4 DINITROPHENOL; 2,4 DINITROPHENYLHYDRAZINE; BIOLOGICAL MARKER; CARBONYL DERIVATIVE; PROTEIN;

ALZHEIMER DISEASE; CHRONIC KIDNEY FAILURE; DERIVATIZATION; DIABETES MELLITUS; ELECTROPHORESIS; ENZYME LINKED IMMUNOSORBENT ASSAY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; OXIDATION; OXIDATIVE STRESS; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; RESPIRATORY DISTRESS SYNDROME; REVIEW; RHEUMATOID ARTHRITIS; SEPSIS; WESTERN BLOTTING;

EID: 0037363715     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-8981(03)00003-2     Document Type: Review

References (108)

1. Halliwell B., Gutteridge J. Free radicals in biology and medicine. 1999;Oxford Univ. Press, NY.
2. Dean R.T., Fu S., Stocker R., Davies M.J. Biochemistry and pathology of radical-mediated protein oxidation. Biochem. J. 324:1997;1-18.
3. Berlett B.S., Stadtman E.R. Protein oxidation in aging, disease, and oxidative stress. J. Biol. Chem. 272:1997;20313-20316.
4. Uchida K. Role of reactive aldehyde in cardiovascular diseases. Free Radic. Biol. Med. 28:2000;1685-1696.
5. Stadtman E.R., Berlett B.S. Reactive oxygen-mediated protein oxidation in aging and disease. Chem. Res. Toxicol. 10:1997;485-494.
6. Kim J.G., Sabbagh F., Santanam N., Wilcox J.N., Medford R.N., Parthasarathy S. Generation of a polyclonal antibody against lipid peroxide-modified proteins. Free Radic. Biol. Med. 23:1997;251-259.
7. Chevion M., Berenshtein E., Stadtman E.R. Human studies related to protein oxidation: protein carbonyl content as a marker of damage. Free Radic. Res. 33:2000;S99-S108.
8. Shacter E. Quantification and significance of protein oxidation in biological samples. Drug Metab. Rev. 32:2000;307-326.
9. Beal M.F. Oxidatively modified proteins in aging and disease. Free Radic. Biol. Med. 32(9):2002;797-803.
10. Lyras L., Evans P.J., Shaw P.J., Ince P.G., Halliwell B. Oxidative damage and motor neurone disease difficulties in the measurement of protein carbonyls in human brain tissue. Free Radic. Res. 24(5):1996;397-406.
11. Halliwell B. Oxidative stress, nutrition and health. Experimental strategies for optimisation of nutritional antioxidant intake in humans. Free Radic. Res. 25(1):1996;57-74.
12. Levine R.L., Garland D., Oliver C.N., Amici A., Climent I., Lenz A.et al. Determination of carbonyl content in oxidatively modified proteins. Methods Enzymol. 186:1990;464-478.
13. Lenz A., Costabel U., Shaltiel S., Levine L. Determination of carbonyl groups in oxidatively modified proteins by reduction with tritiated sodium borohydride. Anal. Biochem. 177:1989;419-425.
14. Yan L.J., Sohal R.S. Gel electrophoretic quantitation of protein carbonyls derivatized with tritiated sodium borohydride. Anal. Biochem. 265:1998;176-182.
15. Levine R.L., Williams J., Stadtman E.R., Shacter E. Carbonyl assays for determination of oxidatively modified proteins. Methods Enzymol. 233:1994;346-357.
16. Keller R.J., Halmes N.C., Hinson J.A., Pumford N.R. Immunochemical detection of oxidized proteins. Chem. Res. Toxicol. 6:1993;430-433.
17. Shacter E., Williams J.A., Lim M., Levine R.L. Differential susceptibility of plasma proteins to oxidative modification. Examination by Western blot immunoassay. Free Radic. Biol. Med. 17:1994;429-437.
18. Robinson C.E., Keshavarzian A., Pasco D.S., Frommel T.O., Winshop D.H., Holmes E.W. Determination of protein carbonyl groups by immunoblotting. Anal. Biochem. 266:1999;48-57.
19. Fagan J.M., Sleczka B.G., Sohar I. Quantitation of oxidative damage to tissue proteins. Int. J. Biochem. Cell Biol. 31:1999;751-757.
20. Dalle-Donne I., Rossi R., Giustarini D., Gagliano N., Lusini L., Milzani A.et al. Actin carbonylation: from a simple marker of protein oxidation to relevant signs of severe functional impairment. Free Radic. Biol. Med. 31:2001;1075-1083.
21. De Maria N., Colantoni A., Fagiuoli S., Liu G.J., Rogers B.K., Farinati F.et al. Association between reactive oxygen species and disease activity in chronic hepatitis C. Free Radic. Biol. Med. 21(3):1996;291-295.
22. Reznick A.Z., Packer L. Oxidative damage to proteins: spectrophotometric method for carbonyl assay. Methods Enzymol. 233:1994;263-357.
23. Buss I.H., Chan T.P., Sluis K.B., Domigan N.M., Winterbourn C.C. Protein carbonyl measurement by a sensitive ELISA method. Free Radic. Biol. Med. 23(3):1997;361-366.
24. Smith C., Carney J., Starke-Reed P., Oliver C., Stadtman E.R., Floyd R.et al. Excess brain protein oxidation and enzyme dysfunction in normal aging and in Alzheimer disease. Proc. Natl. Acad. Sci. U. S. A. 88:1991;10540-10543.
25. Bowling A.C., Schulz J.B., Brown R.H. Jr., Beal M.F. Superoxide dismutase activity, oxidative damage, and mitochondrial energy metabolism in familial and sporadic amyotrophic lateral sclerosis. J. Neurochem. 61(6):1993;2322-2325.
26. Grattagliano I., Vendemiale G., Boscia F., Micelli-Ferrari T., Cardia L., Altomare E. Oxidative retinal products and ocular damages in diabetic patients. Free Radic. Biol. Med. 25(3):1998;369-372.
27. Dominguez C., Ruiz E., Gussinye M., Carrascosa A. Oxidative stress at onset and in early stages of type 1 diabetes in children and adolescents. Diabetes Care. 21(10):1998;1736-1742.
28. Telci A., Cakatay U., Salman S., Satman I., Sivas A. Oxidative protein damage in early stage Type 1 diabetic patients. Diabetes Res. Clin. Pract. 50(3):2000;213-223.
29. Telci A., Cakatay U., Kayali R., Erdogan C., Orhan Y., Sivas A.et al. Oxidative protein damage in plasma of type 2 diabetic patients. Horm. Metab. Res. 32(1):2000;40-43.
30. Mantle D., Falkous G., Walker D. Quantification of protease activities in synovial fluid from rheumatoid and osteoarthritis cases: comparison with antioxidant and free radical damage markers. Clin. Chim. Acta. 284(1):1999;45-58.
31. Renke J., Popadiuk S., Korzon M., Bugajczyk B., Wozniak M. Protein carbonyl groups content as a useful clinical marker of antioxidant barrier impairment in plasma of children with juvenile chronic arthritis. Free Radic. Biol. Med. 29(2):2000;101-104.
32. McGrath L.T., Patrick R., Mallon P., Dowey L., Silke B., Norwood W.et al. Breath isoprene during acute respiratory exacerbation in cystic fibrosis. Eur. Respir. J. 16(6):2000;1065-1069.
33. Gladstone I.M. Jr., Levine R.L. Oxidation of proteins in neonatal lungs. Pediatrics. 93(5):1994;764-768.
34. Agarwal S., Sohal R.S. Differential oxidative damage to mitochondrial proteins during aging. Mech. Ageing Dev. 85(1):1995;55-63.
35. Buss I.H., Chan T.P., Sluis K.B., Domigan N.M., Winterbourn C.C. Protein carbonyl measurement by a sensitive ELISA method. Erratum Free Radic. Biol. Med. 24(7-8):1998;1352.
36. Winterbourn C.C., Buss I.H. Protein carbonyl measurement by enzyme-linked immunosorbent assay. Methods Enzymol. 300:1999;106-111.
37. Quinlan G.J., Evans T.W., Gutteridge J.M. Oxidative damage to plasma proteins in adult respiratory distress syndrome. Free Radic. Res. 20(5):1994;289-298.
38. Buss H., Darlow B.A., Winterbourn C.C. Elevated protein carbonyls and lipid peroxidation products correlating with myeloperoxidase in tracheal aspirates from premature infants. Pediatr. Res. 47(5):2000;640-645.
39. Schock B.C., Sweet D.G., Ennis M., Warner J.A., Young I.S., Halliday H.L. Oxidative stress and increased type-IV collagenase levels in bronchoalveolar lavage fluid from newborn babies. Pediatr. Res. 50(1):2001;29-33.
40. Winterbourn C.C., Buss I.H., Chan T.P., Plank L.D., Clark M.A., Windsor J.A. Protein carbonyl measurements show evidence of early oxidative stress in critically ill patients. Crit. Care Med. 28(1):2000;143-149.
41. Zusterzeel P.L., Mulder T.P., Peters W.H., Wiseman S.A., Steegers E.A. Plasma protein carbonyls in nonpregnant, healthy pregnant and preeclamptic women. Free Radic. Res. 33(5):2000;471-476.
42. Zusterzeel P.L., Rutten H., Roelofs H.M., Peters W.H., Steegers E.A. Protein carbonyls in decidua and placenta of pre-eclamptic women as markers for oxidative stress. Placenta. 22(2-3):2001;213-219.
43. Pantke U., Volk T., Schmutzler M., Kox W.J., Sitte N., Grune T. Oxidized proteins as a marker of oxidative stress during coronary heart surgery. Free Radic. Biol. Med. 27(9-10):1999;1080-1086.
44. Himmelfarb J., McMonagle E., McMenamin E. Plasma protein thiol oxidation and carbonyl formation in chronic renal failure. Kidney Int. 58(6):2000;2571-2578.
45. Blackburn A.C., Doe W.F., Buffinton G.D. Protein carbonyl formation on mucosal proteins in vitro and in dextran sulfate-induced colitis. Free Radic. Biol. Med. 27(3/4):1999;262-270.
46. Conrad C.C., Marshall P.L., Talent J.M., Malakowsky C.A., Choi J., Gracy R.W. Oxidized proteins in Alzheimer's plasma. Biochem. Biophys. Res. Commun. 275(2):2000;678-681.
47. Mantle D., Siddique S., Eddeb F., Mendelow A.D. Comparison of protein carbonyl and antioxidant levels in brain tissue from intracerebral haemorrhage and control cases. Clin. Chim. Acta. 312:2001;185-190.
48. Banan A., Choudhary S., Zhang Y., Fields J.Z., Keshavarzian A. Ethanol-induced barrier dysfunction and its prevention by growth factors in human intestinal monolayers: evidence for oxidative and cytoskeletal mechanisms. J. Pharmacol. Exp. Ther. 291(3):1999;1075-1085.
49. Banan A., Zhang Y., Losurdo J., Keshavarzian A. Carbonylation and disassembly of the F-actin cytoskeleton in oxidant induced barrier dysfunction and its prevention by epidermal growth factor and transforming growth factor alpha in a human colonic cell line. Gut. 46:2000;830-837.
50. Banan A., Fitzpatrick L., Zhang Y., Keshavarzian A. OPC-compounds prevent oxidant-induced carbonylation and depolymerization of the F-actin cytoskeleton and intestinal barrier hyperpermeability. Free Radic. Biol. Med. 30(3):2001;287-298.
51. Dalle-Donne I., Rossi R., Giustarini D., Gagliano N., Di Simplicio P., Colombo R.et al. Methionine oxidation as a major cause of the functional impairment of oxidized actin. Free Radic. Biol. Med. 32:2002;927-937.
52. Shacter E. Protein oxidative damage. Methods Enzymol. 319:2000;428-436.
53. Nakamura A., Goto S. Analysis of protein carbonyls with 2,4-dinitrophenyl hydrazine and its antibodies by immunoblot in two-dimensional gel electrophoresis. J. Biochem. 119(4):1996;768-774.
54. Aksenov M.Y., Aksenova M.V., Butterfield D.A., Geddes J.W., Markesbery W.R. Protein oxidation in the brain in Alzheimer's disease. Neuroscience. 103:2001;373-383.
55. Aksenov M.Y., Aksenova M.V., Butterfield D.A., Markesbery W.R. Oxidative modification of creatine kinase BB in Alzheimer's disease brain. J. Neurochem. 74:2000;2520-2527.
56. Conrad C.C., Choi J., Malakowsky C.A., Talent J.M., Dai R., Marshall P.et al. Identification of protein carbonyls after two-dimensional electrophoresis. Proteomics. 1:2001;829-834.
57. Choi J., Malakowsky C.A., Talent J.M., Conrad C.C., Gracy R.W. Identification of oxidized plasma proteins in Alzheimer's disease. Biochem. Biophys. Res. Commun. 293:2002;1566-1570.
58. Ramsay P.L., Demayo F.J., Hegemier S.E., Wearden M.E., Smith C.V., Welty S.E. Clara cell secretory protein oxidation and expression in premature infants who develop bronchopulmonary dysplasia. Am. J. Respir. Crit. Care Med. 164(1):2001;155-161.
59. Himmelfarb J., McMonagle E. Albumin is the major plasma protein target of oxidant stress in uremia. Kidney Int. 60(1):2001;358-363.
60. Castegna A., Aksenov M., Aksenova M., Thongboonkerd V., Klein J., Pierce W.et al. Proteomic identification of oxidatively modified proteins in Alzheimer's disease brain: Part I. Creatine kinase BB, glutamine synthase, and ubiquitin carboxy-terminal hydrolase L-1. Free Radic. Biol. Med. 33(4):2002;562-571.
61. Castegna A., Aksenov M., Thongboonkerd V., Klein J.B., Pierce W.M., Booze R.et al. Proteomic identification of oxidatively modified proteins in Alzheimer's disease brain: Part II. Dihydropyrimidinase-related protein 2, α-enolase and heat shock cognate 71. J. Neurochem. 82:2002;1524-1532.
62. Yan L.J., Orr W.C., Sohal R.S. Identification of oxidized proteins based on sodium dodecyl sulfate-polyacrylamide gel electrophoresis, immunochemical detection, isoelectric focusing, and microsequencing. Anal. Biochem. 263:1998;67-71.
63. Levine R.L. Carbonyl modified proteins in cellular regulation, aging and disease. Free Radic. Biol. Med. 32(9):2002;790-796.
64. Pepper J.R., Mumby S., Gutteridge J.M.C. Sequential oxidative damage, and changes in iron-binding and iron oxidising plasma antioxidants during cardiopulmonary bypass surgery. Free Radic. Res. 21:1994;377-385.
65. Lenz A.G., Jorens P.G., Meyer B., De Backer W., Van Overveld F., Bossaert L.et al. Oxidatively modified proteins in bronchoalveolar lavage fluid of patients with ARDS and patients at-risk for ARDS. Eur. Respir. J. 13(1):1999;169-174.
66. Pavlick K.P., Laroux F.S., Fuseler J., Wolf R.E., Gray L., Hoffman J.et al. Role of reactive metabolites of oxygen and nitrogen in inflammatory bowel disease. Free Radic. Biol. Med. 33(3):2002;311-322.
67. Lih-Brody L., Powell S.R., Collier K.P., Reddy G.M., Cerchia R., Kahn E.et al. Increased oxidative stress and decreased antioxidant defenses in mucosa of inflammatory bowel disease. Dig. Dis. Sci. 41:1996;2078-2086.
68. Banan A., Fields J.Z., Zhang Y., Keshavarzian A. iNOS upregulation mediates oxidant-induced disruption of F-actin and barrier of intestinal monolayers. Am. J. Physiol.: Gastrointest. Liver Physiol. 280:2001;G1234-G1246.
69. Banan A., Wang J.Y., McCormack S.A., Johnson L.R. Relationship between polyamines, actin distribution, and gastric healing in rats. Am. J. Physiol.: Gastrointest. Liver Physiol. 271:1996;G893-G903.
70. Banan A., McCormack S.A., Johnson L.R. Polyamines are required for microtubule formation during gastric mucosal healing. Am. J. Physiol.: Gastrointest. Liver Physiol. 274:1998;G879-G885.
71. Kettle A.J., Winterbourn C.C. Myeloperoxidase - a key regulator of neutrophil oxidant production. Redox Rep. 3:1997;3-15.
72. Singer I.I., Kawka D.W., Scott S., Weidner J.R., Mumford R.A., Riehl T.E.et al. Expression of inducible nitric oxide synthase and nitrotyrosine in colonic epithelium in inflammatory bowel disease. Gastroenterology. 111(4):1996;871-885.
73. Dijkstra G., Moshage H., van Dullemen H.M., de Jager-Krikken A., Tiebosch A.T., Kleibeuker J.H.et al. Expression of nitric oxide synthases and formation of nitrotyrosine and reactive oxygen species in inflammatory bowel disease. J. Pathol. 186(4):1998;416-421.
74. Kimura H., Hokari R., Miura S., Shigematsu T., Hirokawa M., Akiba Y.et al. Increased expression of an inducible isoform of nitric oxide synthase and the formation of peroxynitrite in colonic mucosa of patients with active ulcerative colitis. Gut. 42(2):1998;180-187.
75. Sittipunt C., Steinberg K.P., Ruzinski J.T., Myles C., Zhu S., Goodman R.B.et al. Nitric oxide and nitrotyrosine in the lungs of patients with acute respiratory distress syndrome. Am. J. Respir. Crit. Care Med. 163(2):2001;503-510.
76. Leeuwenburgh C., Rasmussen J.E., Hsu F.F., Mueller D.M., Pennathur S., Heinecke J.W. Mass spectrometric quantification of markers for protein oxidation by tyrosyl radical, copper, and hydroxyl radical in low density lipoprotein isolated from human atherosclerotic plaques. J. Biol. Chem. 272:1997;3520-3526.
77. Fu S., Davies M.J., Stocker R., Dean R.T. Evidence for roles of radicals in protein oxidation in advanced human atherosclerotic plaque. Biochem. J. 333:1998;519-525.
78. Evans P., Lyras L., Halliwell B. Measurement of protein carbonyls in human brain tissue. Methods Enzymol. 300:1999;145-156.
79. Grune T., Reinheckel T., Joshi M., Davies K.J.A. Proteolysis in cultured liver epithelial cells during oxidative stress - role of the multicatalytic proteinase complex, proteasome. J. Biol. Chem. 270:1995;2344-2351.
80. Grune T., Reinheckel T., Davies K.J.A. Degradation of oxidized proteins in K562 human hematopoietic cells by proteasome. J. Biol. Chem. 271:1996;15504-15509.
81. Siems W.G., Zollner H., Grune T., Esterbauer H. Metabolic fate of 4-hydroxynonenal in hepatocytes: 1,4-dihydroxynonene is not the main product. J. Lipid Res. 38:1997;612-622.
82. Griffiths H.R. Antioxidant and protein oxidation. Free Radic. Res. 33:2000;S47-S58.
83. Powell S.A., Gurzenda E.M., Wahezi S.E. Actin is oxidized during myocardial ischemia. Free Radic. Biol. Med. 30:2001;1171-1176.
84. 2-treated actin: assembly and polymer interactions with cross-linking proteins. Biophys. J. 69:1995;2710-2719.
85. Dalle-Donne I., Milzani A., Colombo R. The t-butyl hydroperoxide-induced oxidation of actin Cys-374 is coupled with structural changes in distant regions of the protein. Biochemistry. 38:1999;12471-12480.
86. Milzani A., Rossi R., Di Simplicio P., Giustarini D., Colombo R., Dalle-Donne I. The oxidation produced by hydrogen peroxide on Ca-ATP-G-actin. Protein Sci. 9:2000;1774-1782.
87. Shacter E., Williams J.A., Levine R.L. Oxidative modification of fibrinogen inhibits thrombin-catalyzed clot formation. Free Radic. Biol. Med. 18(4):1995;815-821.
88. Hensley K., Hall N., Subramaniam R., Cole P., Harris M., Aksenov M.et al. Brain regional correspondence between Alzheimer's disease histopathology and biomarkers of protein oxidation. J. Neurochem. 65:1995;2146-2156.
89. Butterfield D.A., Hensley K., Cole P., Subramaniam R., Aksenov M., Aksenova M.et al. Oxidatively induced structural alteration of glutamine synthetase assessed by analysis of spin label incorporation kinetics: relevance to Alzheimer's disease. J. Neurochem. 68:1997;2451-2457.
90. Palinski W., Rosenfeld M.E., Yla-Herttuala S., Gurtner G.C., Socher S.S., Butler S.W.et al. Low-density lipoprotein undergoes oxidative modification in vivo. Proc. Natl. Acad. Sci. U. S. A. 86:1989;1372-1376.
91. Steinberg S., Parthasarathy T.E., Carew J.C., Khoo J.C., Witztum J.L. Modifications of low-density lipoprotein that increase its atherogenecity. N. Engl. J. Med. 320:1989;915-924.
92. Hazell L.J., Arnold L., Flowers D., Waeg G., Malle E., Stocker R. Presence of hypochlorite-modified proteins in human atherosclerotic lesions. J. Clin. Invest. 97:1996;1535-1544.
93. Ferrante R.J., Browne S.E., Shinobu L.A., Bowling A.C., Baik M.J., MacGarvey U.et al. Evidence of increased oxidative damage in both sporadic and familial amyotrophic lateral sclerosis. J. Neurochem. 69:1997;2064-2074.
94. Boscia F., Grattagliano I., Vendemiale G., Micelli-Ferrari T., Altomare E. Protein oxidation and lens opacity in humans. Invest. Ophthalmol. Vis. Sci. 41(9):2000;2461-2465.
95. Range S.P., Dunster C., Knox A.J., Kelly F.J. Treatment of pulmonary exacerbations of cystic fibrosis leads to improved antioxidant status. Eur. Respir. J. 13(3):1999;560-564.
96. Altomare E., Grattagliano I., Vendemiale G., Micelli-Ferrari T., Signorile A., Cardia L. Oxidative protein damage in human diabetic eye: evidence of a retinal participation. Eur. J. Clin. Invest. 27(2):1997;141-147.
97. Varsila E., Pesonen E., Andersson S. Early protein oxidation in the neonatal lung is related to development of chronic lung disease. Acta Paediatr. 84(11):1995;1296-1299.
98. Ando Y., Nyhlin N., Suhr O., Holmgren G., Uchida K., el Sahly M.et al. Oxidative stress is found in amyloid deposits in systemic amyloidosis. Biochem. Biophys. Res. Commun. 232(2):1997;497-502.
99. Lim P.S., Cheng Y.M., Wei Y.H. Increase in oxidative damage to lipids and proteins in skeletal muscle of uremic patients. Free Radic. Res. 36(3):2002;295-301.
100. Chen S.S., Chang L.S., Wei Y.H. Oxidative damage to proteins and decrease of antioxidant capacity in patients with varicocele. Free Radic. Biol. Med. 30(11):2001;1328-1334.
101. Schock B.C., Sweet D.G., Halliday H.L., Young I.S., Ennis M. Oxidative stress in lavage fluid of preterm infants at risk of chronic lung disease. Am. J. Physiol., Lung Cell Mol. Physiol. 281(6):2001;L1386-L1391.
102. Abu-Zidan F.M., Plank L.D., Windsor J.A. Proteolysis in severe sepsis is related to oxidation of plasma protein. Eur. J. Surg. 168(2):2002;119-123.
103. Korolainen M.A., Goldsteins G., Alafuzoff I., Koistinaho J., Pirttila T. Proteomic analysis of protein oxidation in Alzheimer's disease brain. Electrophoresis. 23:2002;3428-3433.
104. Mihm M.J., Yu F., Carnes C.A., Reiser P.J., McCarthy P.M., Van Wagoner D.R.et al. Impaired myofibrillar energetics and oxidative injury during human atrial fibrillation. Circulation. 104(2):2001;174-180.
105. Haycock J.W., Mac Neil S., Mantle D. Differential protein oxidation in Duchenne and Becker muscular dystrophy. Neuroreport. 9(10):1998;2201-2207.
106. Li C.Q., Pignatelli B., Ohshima H. Increased oxidative and nitrative stress in human stomach associated with cagA+ Helicobacter pylori infection and inflammation. Dig. Dis. Sci. 46(4):2001;836-844.
107. Floor E., Wetzel M.G. Increased protein oxidation in human substantia nigra pars compacta in comparison with basal ganglia and prefrontal cortex measured with an improved dinitrophenylhydrazine assay. J. Neurochem. 70(1):1998;268-275.
108. Dimon-Gadal S., Gerbaud P., Therond P., Guibourdenche J., Anderson W.B., Evain-Brion D.et al. Increased oxidative damage to fibroblasts in skin with and without lesions in psoriasis. J. Invest. Dermatol. 114(5):2000;984-989.